Imunon Appoints Josh Blacher as New Interim Chief Financial Officer

Imunon, Inc. announced the appointment of Josh Blacher as its new interim Chief Financial Officer, effective July 1, 2026. Mr. Blacher replaces Jeffrey Church, who is retiring from the position but will continue in a consulting role to ensure a smooth transition.

Key Details

• Appointment: Josh Blacher will serve as interim CFO, principal financial officer, and principal accounting officer, effective July 1, 2026.
• Retirement: Current interim CFO Jeffrey Church will retire effective July 1, 2026, and will continue as a consultant for a monthly retainer of $10,000.
• Service Agreement: Mr. Blacher is appointed via a master services agreement with the financial advisory firm Danforth Health, Inc., at a rate of $475 per hour for his services.